11.06.12
John K. Lynch, Ph.D. has been appointed chief scientific officer at Cedarburg Hauser Pharmaceuticals. In his new role, Dr. Lynch will oversee all scientific operations including the process development, R&D and analytical groups.
Dr. Lynch has served as director of R&D for the last three years, where he oversaw development projects and led the scientific team. Prior to joining the company, Dr. Lynch spent 15 years at Abbott Laboratories, working on a variety of process development and medicinal chemistry projects.
“Dr. Lynch’s promotion is well deserved,” said Cedarburg Hauser’s chief executive officer, Tony Laughrey. “In his time at Cedarburg Hauser, John has successfully led Cedarburg Hauser’s research and development efforts and is the ideal person to head-up the company’s scientific operations.”
Dr. Lynch has served as director of R&D for the last three years, where he oversaw development projects and led the scientific team. Prior to joining the company, Dr. Lynch spent 15 years at Abbott Laboratories, working on a variety of process development and medicinal chemistry projects.
“Dr. Lynch’s promotion is well deserved,” said Cedarburg Hauser’s chief executive officer, Tony Laughrey. “In his time at Cedarburg Hauser, John has successfully led Cedarburg Hauser’s research and development efforts and is the ideal person to head-up the company’s scientific operations.”